Abstract:Analysis of cellular 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-oxo-dGuo) as a biomarker of oxidative DNA damage has been fraught with numerous methodological problems. This is primarily due to artifactual oxidation of dGuo that occurs during DNA isolation and hydrolysis. Therefore, it has become necessary to rely on using the comet assay, which is not necessarily specific for 8-oxo-dGuo. A highly specific and sensitive method based on immunoaffinity purification and stable isotope dilution liquid chromatography (LC)-multiple reaction monitoring (MRM)/mass spectrometry (MS) that avoids artifact formation has now been developed. Cellular DNA was isolated using cold DNAzol (a proprietary product that contains guanidine thiocyanate) instead of chaotropic- or phenol-based methodology. Chelex-treated buffers were used to prevent Fenton chemistry-mediated generation of reactive oxygen species (ROS) and artifactual oxidation of DNA bases. Deferoxamine was also added to all buffers in order to complex any residual transition metal ions remaining after Chelex treatment. The LC-MRM/MS method was used to determine that the basal 8-oxo-dGuo level in DNA from human bronchoalveolar H358 cells was 2.2 +/- 0.4 8-oxo-dGuo/10(7) dGuo (mean +/- standard deviation) or 5.5 +/- 1.0 8-oxo-dGuo/10(8) nucleotides. Similar levels were observed in human lung adenocarcinoma A549 cells, mouse hepatoma Hepa-1c1c7 cells, and human HeLa cervical epithelial adenocarcinoma cells. These values are an order of magnitude lower than is typically reported for basal 8-oxo-dGuo levels in DNA as determined by other MS- or chromatography-based assays. H358 cells were treated with increasing concentrations of potassium bromate (KBrO3) as a positive control or with the methylating agent methyl methanesulfonate (MMS) as a negative control. A linear dose-response for 8-oxo-dGuo formation (r(2) = 0.962) was obtained with increasing concentrations of KBrO3 in the range of 0.05 mM to 2.50 mM. In contrast, no 8-oxo-dGuo was observed in H358 cell DNA after treatment with MMS. At low levels of oxidative DNA damage, there was an excellent correlation between a comet assay that measured DNA single strand breaks (SSBs) after treatment with human 8-oxo-guanine glycosylase-1 (hOGG1) when compared with 8-oxo-dGuo in the DNA as measured by the stable isotope dilution LC-MRM/MS method. Availability of the new LC-MRM/MS assay made it possible to show that the benzo[a]pyrene (B[a]P)-derived quinone, B[a]P-7,8-dione, could induce 8-oxo-dGuo formation in H358 cells. This most likely occurred through redox cycling between B[a]P-7,8-dione and B[a]P-7,8-catechol with concomitant generation of DNA damaging ROS. In keeping with this concept, inhibition of catechol-O-methyl transferase (COMT)-mediated detoxification of B[a]P-7,8-catechol with Ro 410961 caused increased 8-oxo-dGuo formation in the H358 cell DNA.

Age-Dependent Increases in the Oxidative Damage of Dna, Rna, and Their Metabolites in Normal and Senescence-Accelerated Mice Analyzed by Lc-Ms/Ms: Urinary 8-Oxoguanosine As A Novel Biomarker of Aging

Age-Dependent Accumulation of 8-Oxoguanine in the DNA and RNA in Various Rat Tissues

Levels of 8-Oxo-dgsn and 8-Oxo-gsn in Random Urine Are Consistent with 24h Urine in Healthy Subjects and Patients with Renal Disease

Urinary 8-hydroxydeoxyguanosine is a better biomarker of aging in non-smokers

Increased production of 8-oxo-7,8-dihydroguanine in human urine, a novel biomarker of osteoporosis

Age-dependent Down-Regulation of Mitochondrial 8-Oxoguanine DNA Glycosylase in SAM-P/8 Mouse Brain and Its Effect on Brain Aging.

IMMUNOHISTOCHEMICAL STUDY OF DNA OXIDATIVE DAMAGE

Analysis of the Oxidative Damage of DNA, RNA, and Their Metabolites Induced by Hyperglycemia and Related Nephropathy in Sprague Dawley Rats

A Simple Method for the Determination of 8-Oxoguanosine, 8-Oxo-2′-Deoxyguanosine and 8-Iso-Prostaglandin F2α in Human Urine by UHPLC–MS/MS

Increased Oxidative Damage of RNA in Early-Stage Nephropathy in db/db Mice.

Urinary 8-Oxo-7,8-dihydroguanosine As a Potential Biomarker of Frailty for Elderly Patients with Cardiovascular Disease.

Analysis of 7,8-dihydro-8-oxo-2'-deoxyguanosine in cellular DNA during oxidative stress

8-Hydroxyguanosine As a Possible RNA Oxidative Modification Marker in Urine from Colorectal Cancer Patients: Evaluation by Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry.

Oxidative Damage to RNA and Expression Patterns of MTH1 in the Hippocampi of Senescence-Accelerated SAMP8 Mice and Alzheimer’s Disease Patients

Short-term biological variation and Reference change values of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine and 8-oxo-7,8-dihydroguanosine

8-oxoguanine and 8-oxodeoxyguanosine Biomarkers of Oxidative DNA Damage: A Review on HPLC–ECD Determination

Analysis of Neuronal Nitric Oxide Synthase Expression and Increasing Astrogliosis in the Brain of Senescence-Accelerated-Prone 8 Mice

Endogenous oxidative DNA damage, aging, and cancer.

The Ratio of Plasma and Urinary 8-Oxo-gsn Could Be a Novel Evaluation Index for Patients with Chronic Kidney Disease

Evaluation of DNA and RNA Oxidation in Hyperglycemic SD Rats Using ID-LC-MS/MS

Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease